Pepper Bio makes it possible to develop cures with confidence.
Find new targets. Predict the best patients. And know why it works, before you begin. Applying transomic technology that uses phosphoproteomic data, Pepper partners with your R&D teams. We show you where to start — and just how far you can go.
Discovery is in the data.
Pepper has produced concrete results: proofs of concept and published papers across three therapeutic areas that pave the way for better drug discovery.
Discovery is in the data.
Pepper has produced concrete results: proofs of concept and published papers across three therapeutic areas that pave the way for better drug discovery.
Currently working with a paid industry partner on a drug mechanism of action study.
Publication pending
Pre-clinical discovery in untreatable cancers to create a proprietary disease database using transomic data.
Pre-clinical validation with an industry partner for indication expansion into IBD from RA.
Currently working with a paid industry partner on a drug mechanism of action study.
Publication pending
Pre-clinical validation with an industry partner for indication expansion into IBD from RA.
Pre-clinical discovery in untreatable cancers to create a proprietary disease database using transomic data.
See the reality of biological processes thanks to proteomic and phosphoproteomic data.
Understand actual drivers and not just correlation with Pepper’s integrated analysis.
Our platform is the first to use a truly transomic analysis — integrating phosphoproteomics, proteomics, transcriptomics, and genomics. This whole-stack solution to common drug discovery challenges reveals actionable insights others miss.
See the reality of biological processes thanks to proteomic and phosphoproteomic data.
Understand actual drivers and not just correlation with Pepper’s integrated analysis.
Our platform is the first to use a truly transomic analysis — integrating phosphoproteomics, proteomics, transcriptomics, and genomics. This whole-stack solution to common drug discovery challenges reveals actionable insights others miss.
Target identification
Patient stratification
Indication expansion
Lead optimization
Drug combinations
Pepper’s solutions identify new possibilities for advancing your business. It’s an engine for reliable, repeatable commercial success.
CSO & Co-Founder
PhD, MIT
Samantha develops Pepper’s technology. An NSF Graduate Research Fellow, Churchill Scholar, and Goldwater Scholar, she pioneered omics analysis approaches in Electrical Engineering and Computer Science as well as Biological Engineering at MIT, mentored by Douglas Lauffenburger.
CEO & Co-Founder
MBA, Harvard Business School
Head, Biology
PhD, Newcastle University
Head, Business Development
PhD, Brown University
Senior Mathematician
University of British Columbia
Charlie manages development of Pepper's platform and algorithms. Before transitioning to biotech, his research applied high-performance computing to theoretical nuclear physics.
CSO & Co-Founder
PhD, MIT
Samantha develops Pepper’s technology. An NSF Graduate Research Fellow, Churchill Scholar, and Goldwater Scholar, she pioneered omics analysis approaches in Electrical Engineering and Computer Science as well as Biological Engineering at MIT, mentored by Douglas Lauffenburger.
CEO & Co-Founder
MBA, Harvard Business School
Head, Biology
PhD, Newcastle University
Head, Business Development
PhD, Brown University
Senior Mathematician
University of British Columbia
Charlie manages development of Pepper's platform and algorithms. Before transitioning to biotech, his research applied high-performance computing to theoretical nuclear physics.
Contact us to learn how you can work with Pepper. Send us a message, and a member of our team will reach out to you shortly.
